Corticosteroid therapy for chronic active hepatitis B: Is a little too much?

[1]  M. Buti,et al.  Severe hepatic failure after ARA-A-prednisolone for chronic type B hepatitis. , 1987, Gastroenterology.

[2]  J. Hoofnagle,et al.  A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial. , 2020, Annals of internal medicine.

[3]  M. Tong,et al.  A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B , 1986, Hepatology.

[4]  J. Hoofnagle,et al.  Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis , 1986, Hepatology.

[5]  R. Perrillo.  The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication. , 1986, Journal of hepatology.

[6]  H. Thomas,et al.  Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies. , 1986, Journal of hepatology.

[7]  M. Tong,et al.  Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis. , 2008, Liver.

[8]  O. Yokosuka,et al.  Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study. , 1985, Gastroenterology.

[9]  F. Klion,et al.  Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier. , 1985, Archives of internal medicine.

[10]  R. Perrillo,et al.  Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B. , 1985, Gastroenterology.

[11]  A. Lok,et al.  Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease. , 1985, Journal of hepatology.

[12]  E. Sagnelli,et al.  Immunosuppressive therapy in chronic active hepatitis (CAH). A multicentric retrospective study on 867 patients. A report from a study group for CAH of the Italian Association for the study of the liver. , 1984, Hepato-gastroenterology.

[13]  R. Perrillo,et al.  Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis. , 1984, Annals of internal medicine.

[14]  E. Sagnelli,et al.  Effect of Immunosuppressive Therapy on HBsAg‐Positive Chronic Active Hepatitis in Relation to Presence or Absence of HBeAg and Anti‐HBe , 2007, Hepatology.

[15]  J. Rakela,et al.  Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis. , 1983, Gastroenterology.

[16]  C. Lai,et al.  Prednisolone in HBsAg‐positive chronic active hepatitis: Histologic evaluation in a controlled prospective study , 1982, Hepatology.

[17]  S. Sherlock,et al.  Effects of prednisolone/azathioprine in chronic hepatitis B viral infection. , 1982, Gut.

[18]  J. Hoofnagle,et al.  Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. , 1982, Annals of internal medicine.

[19]  T. Merigan,et al.  Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. , 1981, Gastroenterology.

[20]  T. Merigan,et al.  Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. , 1981, The Journal of infectious diseases.

[21]  B. Portmann,et al.  Reactivation of hepatitis B virus infection in two patients: immunofluorescence studies of liver tissue. , 1981, Gastroenterology.

[22]  C. Trépo,et al.  Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. , 1981, The New England journal of medicine.

[23]  E. Sagnelli,et al.  SERUM LEVELS OF HEPATITIS B SURFACE AND CORE ANTIGENS DURING IMMUNOSUPPRESSIVE TREATMENT OF HBsAg-POSITIVE CHRONIC ACTIVE HEPATITIS , 1980, The Lancet.

[24]  M. Rugge,et al.  Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection , 1980 .